BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 16489537)

  • 1. Decline in cervical cancer incidence and mortality in New South Wales in relation to control activities (Australia).
    Taylor R; Morrell S; Mamoon H; Wain G; Ross J
    Cancer Causes Control; 2006 Apr; 17(3):299-306. PubMed ID: 16489537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-grade cervical abnormalities and screening intervals in New South Wales, Australia.
    Schindeler S; Morrell S; Zuo Y; Baker D
    J Med Screen; 2008; 15(1):36-43. PubMed ID: 18416954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent area socioeconomic disparities in U.S. incidence of cervical cancer, mortality, stage, and survival, 1975-2000.
    Singh GK; Miller BA; Hankey BF; Edwards BK
    Cancer; 2004 Sep; 101(5):1051-7. PubMed ID: 15329915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cancer in New Zealand: national and regional trends.
    Cox B; Borman B
    N Z Med J; 1994 Aug; 107(984):323-6. PubMed ID: 8072727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case-control study of the protective benefit of cervical screening against invasive cervical cancer in NSW women.
    Yang B; Morrell S; Zuo Y; Roder D; Tracey E; Jelfs P
    Cancer Causes Control; 2008 Aug; 19(6):569-76. PubMed ID: 18286380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
    Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer in Croatia: state of the art and possibilities for prevention.
    Znaor A; Strnad M
    Coll Antropol; 2007 Apr; 31 Suppl 2():37-40. PubMed ID: 17598503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
    Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
    J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria.
    Vutuc C; Haidinger G; Waldhoer T; Ahmad F; Breitenecker G
    Wien Klin Wochenschr; 1999 May; 111(9):354-9. PubMed ID: 10407996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer.
    Beral V; Hermon C; Muñoz N; Devesa SS
    Cancer Surv; 1994; 19-20():265-85. PubMed ID: 7534630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes from a mass media campaign to promote cervical screening in NSW, Australia.
    Morrell S; Perez DA; Hardy M; Cotter T; Bishop JF
    J Epidemiol Community Health; 2010 Sep; 64(9):777-83. PubMed ID: 19822553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cervical cancer after 10 years of nationally coordinated screening].
    Haldorsen T; Skare GB; Steen R; Thoresen SO
    Tidsskr Nor Laegeforen; 2008 Mar; 128(6):682-5. PubMed ID: 18337847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
    Nguyen VT; Amin J; Law MG; Dore GJ
    J Gastroenterol Hepatol; 2009 Mar; 24(3):436-42. PubMed ID: 19175834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A longitudinal Swedish study on screening for squamous cell carcinoma and adenocarcinoma: evidence of effectiveness and overtreatment.
    Gunnell AS; Ylitalo N; Sandin S; Sparén P; Adami HO; Ripatti S
    Cancer Epidemiol Biomarkers Prev; 2007 Dec; 16(12):2641-8. PubMed ID: 18086769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cervical cancer screening program at a rural community of South Africa.
    Hoque M; Hoque E; Kader SB
    East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cost effectiveness analysis of screening strategies for cervical cancer in Tunisia].
    Lazaar HB; Aounallah-Skhiri H; Oueslati F; Frikha H; Achour N; Hsairi M
    East Mediterr Health J; 2010 Jun; 16(6):602-8. PubMed ID: 20799586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent trends of cancer in Europe: a combined approach of incidence, survival and mortality for 17 cancer sites since the 1990s.
    Karim-Kos HE; de Vries E; Soerjomataram I; Lemmens V; Siesling S; Coebergh JW
    Eur J Cancer; 2008 Jul; 44(10):1345-89. PubMed ID: 18280139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
    Hølund B; Grinsted P
    Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia.
    Vinod SK; Hui AC; Esmaili N; Hensley MJ; Barton MB
    Intern Med J; 2004 Dec; 34(12):677-83. PubMed ID: 15610212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.